Published: Mar, 2018
The global multiplexed diagnostics market has been foreseen in a report by Transparency Market Research (TMR) to witness the dominance of a few players in the otherwise fragmented competitive landscape. Agilent Technologies, Abbott Laboratories, and Thermo Fisher Scientific had secured a majority of the total market share in the recent past. The presence of a handful of leaders could define the nature of the competitive landscape. However, there could also be a significant count of medium and small-scale companies securing minor shares of the market. Leading players operating in the industry had showcased a wide regional presence, their possession of advanced technology, and diverse product portfolios.
TMR has envisaged the global multiplexed diagnostics market to rise at a staggering CAGR of 20.3% during the forecast tenure 2016-2024. By the completion of the final forecast year, revenue earnings worth a US$26.36 bn could be secured by the market. In 2016, the market secured more than a US$6.0 bn. On the basis of end user, the market has been envisioned to crown academic research institutes as a leading segment for the coming years. By region, North America could take hold of a commanding share considering its lead secured in the recent past.
Application in Automation of PCR Amplification Lowers Rate of User Intervention
Tech automation using multiplexed diagnostics has been anticipated to prove to be highly beneficial for scientists who have been looking to incur lower costs while generating large volumes of sample results. This could act as a strong growth factor for the world multiplexed diagnostics market. In a similar manner, players could be involved in several aspects of the healthcare industry.
For instance, the use of multiplexed diagnostics in the automation of polymerase chain reaction (PCR) amplification could help reduce overall efforts required to execute the program. Furthermore, it could assist in lowering the rate of the required user intervention. This equipment automation as researched by TMR analysts could also decrease the chances of causing errors, reduce manual labor, save processing time, and allow higher throughput.
Assay Tests of Multiplexed Diagnostics are Relatively Expensive than Singleplex
The international multiplexed diagnostics market is still in its nascent stage of growth because the concept is relatively new. Most medium and small-scale clients could find it challenging to afford products and solutions offered in the market. On the basis of initial investment, the cost of multiplexed diagnostics assay tests could be exorbitant in comparison with that of singleplex assays tests.
However, there could be scores of opportunities to cash in on due to increasing research and development efforts taken to cater to the rising demand in the international multiplexed diagnostics market. Moreover, increasing applications of multiplexed diagnostics have been expected to set the tone for a valuable growth in the market.
The information presented in this review is based on a TMR report, titled “Multiplexed Diagnostics Market (Technology - Very High Density Multiplexed Assays (> 10,000-plex), High Density Multiplexed Assays (500 ≤ plex ≤ 10,000), Medium Density Multiplexed Assays (plex < 500), Low Density Multiplexed Assays (plex ≤ 5), and Next Generation Sequencing Assays; Application - Infectious Disease Diagnostics, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies, and Pregnancy and Fertility Testing; End User - Academic Research Institutes, Hospitals, Pharmaceutical Companies, Clinical Research Organizations, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
- Handful of players to dominate the otherwise fragmented global multiplexed diagnostics market.
- Boom in research and development to create promising opportunities in the market.
The global multiplexed diagnostics market has been segmented as presented below:
Global Multiplexed Diagnostics Market by Technology
- Very High Density Multiplexed Assays (> 10,000-plex)
- High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
- Medium Density Multiplexed Assays (plex < 500)
- Low Density Multiplexed Assays (plex ≤ 5)
- Next Generation Sequencing Assays
Global Multiplexed Diagnostics Market by Application
- Infectious Disease Diagnostic
- Autoimmune Diseases
- Cardiac Diseases
- Pregnancy and Fertility Testing
Global Multiplexed Diagnostics Market by End User
- Academic Research Institutes
- Pharmaceutical Companies
- Clinical Research Organizations
- Diagnostic Laboratories
Global Multiplexed Diagnostics Market by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia and New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact